Purchase Order SPE2DP26P0320
- Not listed
- Fenwal, Inc., a Lake Zurich, Illinois-based blood technology company and subsidiary of Fresenius Kabi, was awarded a $1,101.28 firm fixed-price purchase order by the Defense Logistics Agency (DLA) on June 18, 2025, for a blood pack with anticoagulant. The contract, which carries an ultimate completion date of August 18, 2025, represents a continuation of Fenwal's established role as a critical supplier of specialized blood collection and transfusion products to the federal government. This award...
- This firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of anticoagulant citrate. The $1,454.88 contract has an ultimate completion date of October 1, 2024 and does not have a set-aside designation. Fenwal is a global blood technology company specializing in products and services for blood collection, separation, storage, and transfusion. The company has a long history of providing a...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of anticoagulant citrate, a specialized medical product used in blood collection, separation, storage, and transfusion. The contract has a ceiling value of $1,431.36 and an ultimate completion date of November 25, 2019. Fenwal, Inc. is a registered vendor with...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
- This federal contract award, valued at $2,727.90, was made by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi. Fenwal, a global blood technology company, will provide the agency with various products and services related to transfusion medicine and cell therapy, including anticoagulants, blood collection assemblies, and preventative maintenance for specialized equipment. The contract has no set-aside designation, and Fenwal has a history of...
- <p>Fenwal, Inc. has been awarded a $7,356.16 firm fixed price purchase order by the Defense Logistics Agency Troop Support Medical to deliver blood packs with anticoagulant. As a global blood technology company and manufacturer of goods, Fenwal will provide the requested blood collection products from its Lake Zurich, Illinois place of performance by September 25, 2023. No set aside designation was associated with this contract award to support the agency's medical supply needs.</p>
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical supplies, for the delivery of blood packs with anticoagulant. The contract has a ceiling value of $3,303.84 and an ultimate completion date of August 18, 2025. Fenwal, Inc. is a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The company is a registered vendor with the U.S. federal...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract is for the supply of a blood pack with an anticoagulant, with a ceiling value of $1,101.28 and an ultimate completion date of August 4, 2025. The contract does not have a set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government,...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract, valued at $41,848.64, is for the delivery of blood packs with anticoagulants to support the agency's medical supply chain operations. Fenwal, Inc. is a registered federal vendor that has consistently secured contracts from various agencies, including the DLA, National...
- This is a federal contract award (SPE2DP24P0665) from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Fenwal, Inc., a subsidiary of Fresenius Kabi. The $1,818.60 firm fixed price purchase order is for the supply of ANTICOAGULANT CITRA products, with a period of performance ending on September 27, 2024. Fenwal, a global blood technology company, has established itself as a key supplier to various federal agencies, including the Department of Defense, Department of...
Fenwal, Inc., a Lake Zurich, Illinois-based blood technology manufacturer and subsidiary of Fresenius Kabi, has been awarded a firm fixed-price purchase order valued at $1,214.16 by the Defense Logistics Agency Medical Supply Chain for Anticoagulant Citra products. The contract, awarded January 27, 2026, carries an ultimate completion date of February 11, 2026, and was issued without a set-aside designation, reflecting Fenwal's specialized capabilities in transfusion medicine. As the prime contractor, Fenwal will deliver anticoagulant citrate products that support critical blood banking and transfusion operations across the Department of Defense medical supply chain. This award is consistent with Fenwal's established role as a key federal supplier of blood collection, separation, storage, and transfusion products to multiple defense and health agencies. The company's federal contract portfolio encompasses a comprehensive range of blood-related consumables and equipment, including blood packs, anticoagulant solutions, apheresis kits, and preventive maintenance services for specialized medical devices. With federal vendor registration since April 2007, Fenwal has demonstrated sustained capacity to meet the exacting requirements of military medical operations and continues to support critical healthcare missions across the Department of Defense and other federal health agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/26/26 |